Future clinical trials should refine the investigation of the direct analgesic properties of GLP-1RAs in osteoarthritis, differentiating these from the benefits linked to weight reduction, to better evaluate their clinical utility in managing osteoarthritis-related pain
These decisions are made individually after thorough evaluation
A direct question to your prescriber settles it
Louis, MO and the National Institutes of Health, Bethesda, MD
Sign up to our newsletter for personalised health articles that make a difference
Oral semaglutide in adults with obesity without diabetes (OASIS 1): A randomized, double-blind, placebo-controlled, phase 3 trial